Successful Immunoglobulin Treatment in Severe Cryptogenic Organizing Pneumonia Caused by Dermatomyositis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In connective tissue diseases, autoantibodies cause pulmonary interstitial inflammation and fibrosis, and patients require treatment with an immunosuppressive agent such as a steroid. Dermatomyositis is an incurable, uncommon form of connective tissue disease that occasionally causes diffuse pulmonary inflammation leading to acute severe respiratory failure. In such cases, the prognosis is very poor despite treatment with high-dose steroid. In the present case, a 46-year-old man was admitted to our hospital with dyspnea. He was diagnosed with dermatomyositis combined with cryptogenic organizing pneumonia (COP) with respiratory failure and underwent treatment with steroid and an immunosuppressive agent, but the COP was not improved. However, the respiratory failure did improve after treatment with intravenous immunoglobulin, which therefore can be considered a treatment option in cases where steroids and immunosuppressive agents are ineffective.
Abstract
In connective tissue diseases, autoantibodies cause pulmonary interstitial inflammation and fibrosis, and patients require treatment with an immunosuppressive agent such as a steroid. Dermatomyositis is an incurable, uncommon form of connective tissue disease that occasionally causes diffuse pulmonary inflammation leading to acute severe respiratory failure. In such cases, the prognosis is very poor despite treatment with high-dose steroid. In the present case, a 46-year-old man was admitted to our hospital with dyspnea. He was diagnosed with dermatomyositis combined with cryptogenic organizing pneumonia (COP) with respiratory failure and underwent treatment with steroid and an immunosuppressive agent, but the COP was not improved. However, the respiratory failure did improve after treatment with intravenous immunoglobulin, which therefore can be considered a treatment option in cases where steroids and immunosuppressive agents are ineffective.
참고문헌 (17)
- Bohan A, "Polymyositis and dermatomyositis (second of two parts)", N Engl J Med, 292, pp.403~407 (1975)
- Keir GJ, "Rituximab in severe, treatment-refractory interstitial lung disease", Respirology, 19, pp.353~359 (2014)
- Brulhart L, "Rituximab in the treatment of antisynthetase syndrome", Ann Rheum Dis, 65, pp.974~975 (2006)
- Keir GJ, "Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy", Eur Respir J, 40, pp.641~648 (2012)
- Suzuki Y, "Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis", dermatomyositis, 2009, pp.187, 201~206
- Castelino FV, "Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management", Arthritis Res Ther, 12, pp.213~ (2010)
- Douglas WW, "Polymyositis–dermatomyositis-associated interstitial lung disease", Am J Respir Crit Care Med, 164, pp.1182~1185 (2001)
- Marie I, "Interstitial lung disease in polymyositis and dermatomyositis", Arthritis Rheum, 47, pp.614~622 (2002)
- Purcell IF, "Cyclophosphamide in severe steroid-resistant bronchiolitis obliterans organizing pneumonia", Respir Med, 91, pp.175~177 (1997)
- Cohen AJ, "Rapidly progressive bronchiolitis obliterans with organizing pneumonia", Am J Respir Crit Care Med, 149, pp.1670~1675 (1994)
- Fathi M, "Pulmonary complications of polymyositis and dermatomyositis", Semin Respir Crit Care Med, 28, pp.451~458 (2007)
- Ando K, "Effect of glucocorticoid monotherapy on pulmonary function and survival in Japanese patients with scleroderma-related interstitial lung disease", Respir Investig, 51, pp.69~75 (2013)
- Horai Y, "Early diagnosis and treatment for remission of clinically amyopathic dermatomyositis complicated by rapid progress interstitial lung disease: a report of two cases", Mod Rheumatol, 23, pp.190~194 (2013)
- Kameda H, "Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute", subacute interstitial pneumonia in patients with dermatomyositis, 2005, pp.32, 1719~1726
- Danieli M, "Cyclosporin A and intravenous immunoglobulin treatment in polymyositis", dermatomyositis, 2002, pp.61, 37~41
- Bakewell C.J, "Polymyositis associated with severe interstitial lung disease: remission after three doses of IV immunoglobulin", Chest, 139, pp.441~443 (2011)
- Miyazaki E, "Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis", Clin Rheumatol, 26, pp.436~439 (2007)